Avricore Health Inc
Avricore Health Inc. engages in the health data and point-of-care technologies business. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018… Read more
Avricore Health Inc (AVCRF) - Total Assets
Latest total assets as of September 2025: $1.33 Million USD
Based on the latest financial reports, Avricore Health Inc (AVCRF) holds total assets worth $1.33 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Avricore Health Inc - Total Assets Trend (2000–2024)
This chart illustrates how Avricore Health Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Avricore Health Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Avricore Health Inc's total assets of $1.33 Million consist of 68.9% current assets and 31.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 49.3% |
| Accounts Receivable | $419.59K | 18.3% |
| Inventory | $507.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $59.15K | 2.6% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2000–2024)
This chart illustrates how Avricore Health Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Avricore Health Inc's current assets represent 68.9% of total assets in 2024, an increase from 64.4% in 2000.
- Cash Position: Cash and equivalents constituted 49.3% of total assets in 2024, down from 62.0% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2000.
- Asset Diversification: The largest asset category is accounts receivable at 18.3% of total assets.
Avricore Health Inc Competitors by Total Assets
Key competitors of Avricore Health Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Revvity Inc.
NYSE:RVTY
|
USA | $12.17 Billion |
|
SMO ClinPlus Co. Ltd.
SHE:301257
|
China | CN¥1.47 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Avricore Health Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Avricore Health Inc generates 2.08x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Avricore Health Inc is currently not profitable relative to its asset base.
Avricore Health Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 17.92 | 2.62 | 0.38 |
| Quick Ratio | 17.81 | 2.62 | 0.38 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $608.15K | $ 868.07K | $ -714.04K |
Avricore Health Inc - Advanced Valuation Insights
This section examines the relationship between Avricore Health Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.63 |
| Latest Market Cap to Assets Ratio | 1.40 |
| Asset Growth Rate (YoY) | -9.4% |
| Total Assets | $2.30 Million |
| Market Capitalization | $3.22 Million USD |
Valuation Analysis
Above Book Valuation: The market values Avricore Health Inc's assets above their book value (1.40 x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Avricore Health Inc's assets decreased by 9.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Avricore Health Inc (2000–2024)
The table below shows the annual total assets of Avricore Health Inc from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $2.30 Million | -9.44% |
| 2023-12-31 | $2.54 Million | -1.20% |
| 2022-12-31 | $2.57 Million | +12.61% |
| 2021-12-31 | $2.28 Million | +418.39% |
| 2020-12-31 | $440.09K | +111.18% |
| 2019-12-31 | $208.40K | -82.64% |
| 2018-12-31 | $1.20 Million | -58.62% |
| 2017-12-31 | $2.90 Million | +27.46% |
| 2016-12-31 | $2.28 Million | -35.74% |
| 2015-12-31 | $3.54 Million | +331.56% |
| 2014-12-31 | $820.42K | +2.43% |
| 2013-12-31 | $800.99K | 0.00% |
| 2012-12-31 | $800.99K | +320.48% |
| 2011-12-31 | $190.49K | -81.07% |
| 2010-12-31 | $1.01 Million | -69.15% |
| 2009-12-31 | $3.26 Million | +51.42% |
| 2008-12-31 | $2.15 Million | +152.15% |
| 2007-12-31 | $854.17K | 0.00% |
| 2006-12-31 | $854.17K | +293.86% |
| 2005-12-31 | $216.87K | -27.92% |
| 2004-12-31 | $300.89K | -63.78% |
| 2003-12-31 | $830.76K | +189.93% |
| 2002-12-31 | $286.54K | +50.99% |
| 2001-12-31 | $189.77K | +125.97% |
| 2000-12-31 | $83.98K | -- |